As companies mature, in our Long-term Islet we transition to more passive ownership, balancing our portfolio with new investments while realizing gains from mature holdings.

Replacing animal testing with best-in-class in vitro technology.

genovis-logo-600x128.png

Unique enzymes and technologies for analytical characterization and conjugation of biopharmaceuticals.

ossdsign.png

Dedicated to creating regenerative implants for improved healing of bone defects.

Best-in-class novel enzymes